TY - JOUR
T1 - Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics
AU - Banerjee, Ankita
AU - Pradhan, Lilesh Kumar
AU - Sahoo, Pradyumna Kumar
AU - Jena, Kautilya Kumar
AU - Chauhan, Nishant Ranjan
AU - Chauhan, Santosh
AU - Das, Saroj Kumar
N1 - Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2021/8
Y1 - 2021/8
N2 - Increasing incidences of neurological disorders, such as Parkinson’s disease (PD), multiple sclerosis (MS), Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS) are being reported, but an insight into their pathology remains elusive. Findings have suggested that gut microbiota play a major role in regulating brain functions through the gut–brain axis. A unique bidirectional communication between gut microbiota and maintenance of brain health could play a pivotal role in regulating incidences of neurodegenerative diseases. Contrarily, the present life style with changing food habits and disturbed circadian rhythm may contribute to gut homeostatic imbalance and dysbiosis leading to progression of several neurological disorders. Therefore, dysbiosis, as a primary factor behind intestinal disorders, may also augment inflammation, intestinal and blood–brain barrier permeability through microbiota–gut–brain axis. This review primarily focuses on the gut–brain axis functions, specific gut microbial population, metabolites produced by gut microbiota, their role in regulating various metabolic processes and role of gut microbiota towards development of neurodegenerative diseases. However, several studies have reported a decrease in abundance of a specific gut microbial population and a corresponding increase in other microbial family, with few findings revealing some contradictions. Reports also showed that colonization of gut microbiota isolated from patients suffering from neurodegenerative disease leads to the development of enhance pathological outcomes in animal models. Hence, a systematic understanding of the dominant role of specific gut microbiome towards development of different neurodegenerative diseases could possibly provide novel insight into the use of probiotics and microbial transplantation as a substitute approach for treating/preventing such health maladies.
AB - Increasing incidences of neurological disorders, such as Parkinson’s disease (PD), multiple sclerosis (MS), Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS) are being reported, but an insight into their pathology remains elusive. Findings have suggested that gut microbiota play a major role in regulating brain functions through the gut–brain axis. A unique bidirectional communication between gut microbiota and maintenance of brain health could play a pivotal role in regulating incidences of neurodegenerative diseases. Contrarily, the present life style with changing food habits and disturbed circadian rhythm may contribute to gut homeostatic imbalance and dysbiosis leading to progression of several neurological disorders. Therefore, dysbiosis, as a primary factor behind intestinal disorders, may also augment inflammation, intestinal and blood–brain barrier permeability through microbiota–gut–brain axis. This review primarily focuses on the gut–brain axis functions, specific gut microbial population, metabolites produced by gut microbiota, their role in regulating various metabolic processes and role of gut microbiota towards development of neurodegenerative diseases. However, several studies have reported a decrease in abundance of a specific gut microbial population and a corresponding increase in other microbial family, with few findings revealing some contradictions. Reports also showed that colonization of gut microbiota isolated from patients suffering from neurodegenerative disease leads to the development of enhance pathological outcomes in animal models. Hence, a systematic understanding of the dominant role of specific gut microbiome towards development of different neurodegenerative diseases could possibly provide novel insight into the use of probiotics and microbial transplantation as a substitute approach for treating/preventing such health maladies.
KW - Dysbiosis
KW - Gut microbiota
KW - Gut–brain axis
KW - Microbial transplantation
KW - Neurodegenerative diseases
KW - Probiotics
UR - http://www.scopus.com/inward/record.url?scp=85103182982&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103182982&partnerID=8YFLogxK
U2 - 10.1007/s00203-021-02276-9
DO - 10.1007/s00203-021-02276-9
M3 - Article
C2 - 33763767
AN - SCOPUS:85103182982
SN - 0302-8933
VL - 203
SP - 2895
EP - 2910
JO - Archives of Microbiology
JF - Archives of Microbiology
IS - 6
ER -